Location: Home
  • search
  • go
  • News
  • 3/19/2024China to Expand Pilot Program for Medical Services Pricing Reform
  • 3/18/2024CDE Publicizes the List of Reference Formulations for GQCE Studies (80...
  • 3/18/2024Bio-Thera Solutions Partners with SteinCares to Market Two Biosimilars...
  • 3/15/2024Drug R&D and Product Registration News Digest March 2024 (2)
  • 3/15/2024Recent Executive Moves
  • 3/15/2024Unveiling Quality of Clinical Trial in China: from Concern to Confirma...
  • 3/15/2024Biotheus and Hansoh Pharma Expand ADC Collaboration
  • 3/15/2024Chinese Pharma Stocks Surge amid Speculation of Government Support for...
  • 3/14/2024PhIIC: Review of Prescription Drug Sales Trends in Chinese Retail Phar...
  • 3/14/2024Sinohealth: Review of Chinese Retail Pharmacy Drug Sales and Top 20 Pr...
  • 3/13/2024Biotech Lobby Group BIO to Sever Ties with WuXi Amid National Security...
  • 3/13/2024IQVIA: Chinese Hospital Drug Market Rose 4.2% in 2023 (MAT Q4/2023)
  • 3/12/2024BIO Faces Criticism for Involvement in Legislation Concerning China's ...
  • 3/12/2024CDE Issues the List of Reference Formulations for GQCE Studies (78th B...
  • 3/11/2024Johnson & Johnson Completes Acquisition of Ambrx
  • 3/8/2024Drug R&D and Product Registration News Digest March 2024 (1)
  • 3/8/2024Recent Official Changes and Executive Moves
  • 3/7/2024Novo Nordisk Expects Chinese Approval for Weight Loss Drug Wegovy This...
  • 3/6/2024China's Medical App Revolution Spearheaded by Ping An Good Doctor with...
  • 3/6/2024Shanghai's Progressive Health Insurance Initiatives: Paving the Way fo...
  • 3/6/2024Biopharma Delegates Advocate for Policy Reforms During China's Two Ses...
  • 3/6/2024US Senate Committee Approves Bill That Could Restrict Chinese Biotech
  • 3/6/2024CDE's Annual Review of Chinese Drug Evaluation and Registration in 202...
  • 3/5/20242024 Chinese Government Work Report Highlights with Emphasis on Health...
  • 3/5/2024NMPA Announces Package Insert Revision of Synovitis Formulations
  • 3/3/2024China to Expand Basic Medical Insurance Coverage for Children
  • 3/3/2024AstraZeneca Signs $475 Million Deal for Innovative Drug Facility in Wu...
  • 3/3/2024Bitterroot Bio and Biotheus Enter Research Partnership to Develop Bisp...
  • 3/3/2024Mabwell Out-Licenses Ex-China Rights of Rare Disease Drug to Disc Medi...
  • 3/3/2024Haihe and Taiho Enter Exclusive License Deal for Anticancer Gumarontin...
  • Page:4/32 Total number of articles:944: [First][<<] [2] [3] [4] [5] [6] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group